Zobrazeno 1 - 10
of 100
pro vyhledávání: '"P.H. Degen"'
Autor:
P.H. Degen, Sharif Mahsufi Mansor, V. Navaratnam, N.K. Nair, Norizah Yahaya, Walther H. Wernsdorfer
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 682:321-325
A rapid and selective high-performance liquid chromatographic assay for determination of a new antimalarial drug (benflumetol, BFL) is described. After extraction with hexane-diethyl ether (70:30, v/v) from plasma, BFL was analysed using a C18 Partis
Autor:
P. Zbinden, P.H. Degen
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 681:339-345
A specific and sensitive liquid chromatographic assay for the determination of 4-amidino-1-indanone-2'-amidinohydrazone (CGP 48 664, I) and a potential metabolite, 2-(4-carbamoyl-2,3-dihydro-1H-inden-1-yliden) hydrazine carboximidamide (CGP 53 391, I
Publikováno v:
Biopharmaceutics & Drug Disposition. 16:603-614
A study was performed in ten patients, stabilized with oxcarbazepine monotherapy (450–750 mg bid) for two weeks minimum, to investigate the possibility of using saliva to monitor the oxcarbazepine therapy. Thirteen paired blood and saliva samples w
Publikováno v:
Journal of Chromatography A. 623:191-195
A significantly improved method for the determination of the monoamine oxidase A inhibitor brofaromine hydrochloride and its major metabolite is described. A newly constructed multi-purpose injector for capillary column gas chromatography (cGC) was u
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 581:147-151
An enantioselective liquid chromatographic assay for the simultaneous determination of the S-(+) and R-(-) enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma is described. The metabolite is the active principle. The metho
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 568:261-266
An improved method for the determination of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate (pamidronate) in human urine and plasma is described. The procedure is based on a co-precipitation of the bisphosphonates (pamidronate and 6-amino-1-hydroxype
Autor:
W. Schneider, P.H. Degen
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 565:67-73
A sensitive and specific quantitative assay has been developed for the determination of 4-hydroxyandrostenedione (4-OHA), a potent aromatase inhibitor used in the treatment of estrogen-dependent breast cancer. This steroid has a high first-pass metab
Publikováno v:
Journal of chromatography. B, Biomedical sciences and applications. 696(1)
A liquid chromatographic assay for the determination of CGP 61755 (I) in plasma and urine is described. A similar method for CGP 53437, another HIV-1 protease inhibitor, has been developed and reported previously. After a deproteinization step, a liq
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 15(12)
Zoledronate, 2-(imidazole-1-yl)-1-hydroxyethane-1,1-bisphosphonic acid is a new 3rd generation bisphosphonate. A specific enzyme inhibition assay was developed for the determination of zoledronate in plasma of animals and man. The multistep synthesis
Publikováno v:
Biopharmaceuticsdrug disposition. 15(6)
The effect of food on the pharmacokinetics of the antiepileptic oxcarbazepine (OXC) was investigated in healthy volunteers. Six healthy male volunteers were treated with single peroral doses of 600 mg of oxcarbazepine (Trileptal) after overnight fast